Editor's Note A new brain implant could one day restore voices to those who can no longer speak, the Associated Press (AP) reported March 31. As detailed in the article, researchers have successfully tested the experimental brain-computer interface (BCI) on a 47-year-old woman with quadriplegia who lost the ability to…

Read More

Editor's Note Arthroplasty implants may release metals that accumulate in the central nervous system (CNS), potentially contributing to neurotoxic effects, according to a study published March 28 in JAMA Network Open. Researchers found that patients with large joint replacements had significantly higher levels of cobalt, chromium, titanium, niobium, and zirconium…

Read More

Editor's Note A new noninvasive procedure called magnetic resonance-guided focused ultrasound (MRgFUS) capsulotomy is showing promising results for patients with severe obsessive-compulsive disorder (OCD), Asian Scientist March 26 reports. In a study conducted by researchers in South Korea and published in Molecular Psychiatry, 10 individuals who received MRgFUS capsulotomy at…

Read More

Editor's Note A newly refined 7T MRI imaging technique may significantly improve outcomes for people with hard-to-treat focal epilepsy by revealing tiny brain lesions that standard imaging methods often miss, HealthDay March 26 reports from a new study published in the journal Epilepsia. Researchers achieved this advance by implementing “parallel…

Read More

Editor's Note A new genetic testing tool could allow surgeons to accurately identify cancer cells in real time during brain surgery, potentially improving surgical outcomes and reducing cancer recurrence, NYU Langone Health System announced.  According to a February 25 press release, the Ultra-Rapid droplet digital PCR (UR-ddPCR) technique identifies cancer…

Read More

Editor's Note Known for managing Type 2 diabetes and promoting weight loss, GLP-1 drugs like Ozempic and Wegovy may also reduce the risks of numerous other conditions, including Alzheimer’s, substance use disorders, and certain cancers, according to an article published in Fortune January 20. Led by the Veterans Affairs St.…

Read More

Editor's Note A mass spectrometry platform that identifies key brain cancer mutations in real-time during surgery shows potential for improving outcomes in a procedure when time is of utmost importance, Technology Networks reported June 3. Developed by the Mayo Clinic, the platform specifically targets dehydrogenase (IDH) mutations on samples taken…

Read More

Editor's Note The US Food & Drug Administration (FDA) has classified Medtronic’s recall of its StealthStation S8 software as a Class I, the most severe category indicating risk of serious injury or death. The StealthStation System with StealthStation Cranial software is intended as an aid for locating anatomical structures during…

Read More

Editor's Note Microscopic stainless steel debris on the insides of biopsy needles prompted the FDA to issue a class 1 recall—indicating risk of death or serious injury—for Elekta Instrument’s Disposable Biopsy Needle Kit, which is used with the Leksell Stereotactic System for brain tissue sampling during neurosurgery, the disposable biopsy…

Read More

Editor's Note Medical management care with evacuation surgery could yield better 180-day outcomes than without in patents treated within 24 hours for acute intracerebral hemorrhage, according to study results covered in an April 10 MedPage Today report. The ENRICH (Early MiNimally-invasive Removal of IntraCerebral Hemorrhage (ICH)) trial is a multicenter,…

Read More